middle.news
Telix Opens US Brain Cancer Imaging Market with Pixclara Approval
8:21am on Monday 14th of September, 2026 AEST
•
Biotechnology and Pharmaceuticals
Read Story
Telix Opens US Brain Cancer Imaging Market with Pixclara Approval
8:21am on Monday 14th of September, 2026 AEST
Key Points
First FDA-approved FET-PET drug for glioma in the US
Approved for adults and children aged one month and older
Designed to distinguish recurrent or progressive glioma from treatment-related change
Adds Pixclara to Telix’s commercial precision diagnostics portfolio
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Telix Pharmaceuticals (ASX:TLX)
OPEN ARTICLE